SNMMI Names Nizar Mullani of TransLite LLC as 2023 Georg Charles de Hevesy Nuclear Pioneer Award Recipient
Sugar Land, TX (PRWEB) June 29, 2023 -- TransLite LLC, manufacturer of Veinlite® brand vein finders, is proud to announce that its esteemed owner and President, Mr. Nizar Mullani, has been named the recipient of the prestigious 2023 SNMMI Georg Charles de Hevesy Nuclear Pioneer Award. This distinguished honor recognizes Mr. Mullani's trailblazing contributions to the development of the first Positron Emission Tomography (PET) prototype, revolutionizing the field of nuclear medicine.
The SNMMI Georg Charles de Hevesy Nuclear Pioneer Award is bestowed upon individuals who have demonstrated exceptional leadership, innovation, and impact within the nuclear medicine community. Mr. Mullani's visionary work in advancing PET technology has significantly contributed to the diagnosis and treatment of various medical conditions, offering patients around the world access to more accurate and personalized healthcare solutions.
“The scope of Nizar’s work throughout his career is formidable,” said SNMMI president Munir Ghesani, MD, FACNM, FACR. “Not only was he involved with the invention of PET as we know it today, but also he has contributed to countless other advances that are now used on a daily basis, allowing innovative and safer practice of medicine and benefitting thousands of patients every day.”
Mr. Mullani's career spans over five decades, during which he has consistently exhibited an unwavering commitment to excellence and a passion for advancing medical technologies. In addition to his pioneering work in PET imaging, he is also recognized for creating numerous other medical devices, including the Veinlite® and DermLite® product brands.
"We are thrilled and proud to congratulate Mr. Nizar Mullani on receiving the 2023 SNMMI Georg Charles de Hevesy Nuclear Pioneer Award," said Kelsea Last, Vice President of TransLite LLC. "Mr. Mullani's remarkable achievements in the development of PET technology, vein visualization and skin imaging have had a profound impact on patient care."
TransLite LLC has been at the forefront of medical device innovation under Mr. Mullani's guidance, and his recognition with the SNMMI Georg Charles de Hevesy Nuclear Pioneer Award further solidifies the company's commitment to excellence and cutting-edge advancements. As the makers of Veinlite vein access devices, TransLite LLC remains dedicated to improving patient outcomes and enhancing healthcare providers' abilities to administer crucial medical procedures effectively.
About TransLite LLC:
TransLite LLC designs and manufactures Veinlite® vein finders. Veinlite® devices enable medical professionals to locate and access veins during IV access procedures with greater accuracy and speed. TransLite is committed to developing innovative medical technologies that improve the quality, safety and efficacy of patient care. With a focus on precision and reliability, TransLite remains focused on pushing the boundaries of medical device innovation and advancing the field of healthcare.
Kelsea Last, TransLite LLC, https://www.veinlite.com, 1 (281) 240-3111, [email protected]
Share this article